Life sciences

We have one of the most renowned life sciences practices in the UK. We help leading companies to commercialise their technology and scientific discoveries. Our life sciences practice helps companies bring more innovative drugs, therapies and devices to the market, enabling people to live longer and healthier lives.

Our dedicated life sciences team has extensive experience advising entrepreneurs, investors, and technology companies, operating in a range of sectors, including biotech, med-tech, food tech and health-tech (including digital health).

From inception to exit, we are familiar with the life cycle of life sciences companies and the demands on scaling your business. From structuring and fundraising for early stage companies to M&A and IPO for later stage companies.

Charitable funding

Our renowned charities team advises some of the leading charities in healthcare and research. We advise charities on governance and structuring issues where research is funded through charitable grants, social and financial investments. The team also advises organisations receiving charitable funding or investment.

Technology transfers & spin-outs

Our team has a successful record of transferring technology and launching spin-out companies from notable universities, research institutions and tech accelerators. Our experience includes advising on investment and shareholder rights, and drafting and negotiating licensing documents and technology transfer agreements, including technology access through pipeline agreements, options and rights of first refusal.

General counsel

For organisations whose business is simply growing beyond their existing legal capacity or which do not yet have budget for full time in-house lawyer, we offer general counsel support, whether at project specific fees and/or on a fixed monthly budget to meet your needs.

For further help or information

Get in touch

Withers tech

Tech law firm JAG Shaw Baker has joined us to create a unique legal offering that meets the needs of entrepreneurs, investors and technology companies across the world.

Find out more

18 October 2019 - Article

Dealing with Italian società semplici in a UK tax context


Подробнее

Награды и признание

2019 STEP Winner: People's Choice - Trusted Advisor of the Year

2019 STEP Winner: International Legal Team of the Year (large firm)

2019 Legal Community Awards: Studio dell'Anno Food

Познакомьтесь с нашей командой

Опыт работы

Advised Mologic Limited, a UK biotech on a collaboration agreement with another UK biotech for peptide selection.

Advised the client on the financial element of the deal including clinical development milestones, first product sale in US, EU and Japan and net commercialisation revenues

Acting as General Counsel for Bioven

Acting as General Counsel for Bioven, an international biotech company on all legal matters worldwide dealing with high value negotiations and contracts with third parties including pre-clinical trials and Phase III clinical trials.

Advising Omega Funds on their equity investment into BioSilta Holdings Ltd

Advising Omega Funds on their equity investment into BioSilta Holdings Ltd, a company that develops advanced microbial growth systems, involving a UK flip from a Finnish company and subsequent equity investment.

Acted for the founders of Morphogen-IX

Acted for the founders of Morphogen-IX, in respect of its spin out from Cambridge University and Series A funding from Medicxi Ventures.

Acted for Medovate Limited

Acted for Medovate Limited, in respect of the set up and venture capital funding of this company established to enable and promote the commercialisation of intellectual property and medical products from NHS Trust in East Anglia.

Would you like to hear more from us?

Visit our subscriptions page to tell us a bit more about what you’re interested in so we can send you relevant news.